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Abstract
Invasive bacterial disease is well described in immunocompromised hosts, including those with
malaria infection. One bacterial infection frequently observed in children with Plasmodium falci-
parum infection is nontyphoidal salmonella (NTS) infection, in which a typically intestinal infection
becomes systemic with serious, often fatal, consequences. In this review, we consider the role of
malaria-induced immunoregulatory responses in tipping the balance from tissue homeostasis dur-
ing malaria infection to risk of invasive NTS. Also, neutrophils are crucial in the clearance of NTS
but their ability to mount an oxidative burst and kill intracellular Salmonella is severely compro-
mised during, and for some time after, an acute malaria infection. Here, we summarize the evi-
dence linkingmalaria and invasive NTS infections; describe the role of neutrophils in clearing NTS
infections; review evidence for neutrophil dysfunction in malaria infections; and explore roles of
heme oxygenase-1, IL-10, and complement in mediating this dysfunction. Finally, given the epi-
demiological evidence that low density, subclinical malaria infections pose a risk for invasive NTS
infections, we consider whether the high prevalence of such infections might underlie the very
high incidence of invasive bacterial disease across much of sub-Saharan Africa.
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1 BACTEREMIA AND MALARIA
Bloodstream bacterial infections remain a global health concern, with
high case fatality rates and the potential for long-term, life-changing
sequelae. Life-threatening organ dysfunction resulting from systemic
bacterial infection, or more commonly sepsis,1 is mediated by a sys-
temic inflammatory response2,3 wherein septic shock leads to severe
tissue damage and death.4,5 Sepsis is one of the most challenging
and most costly conditions to treat in hospital—amassing a bill of
$24 billion in the United States for 2013 alone.6
In developed economies, the organisms most frequently isolated
from blood include Staphylococcus aureus and Escherichia coli7 (each
accounting for ∼20% of cases). Methicillin-resistant S. aureus8 and
highly pathogenic E. coli are emerging as major causes of nosoco-
mial infections.9 In contrast, developing nations in Africa see a much
greater incidence of community-acquired bacteremia with Salmonella
Abbreviations: Hmox1, heme oxygenase-1 gene; HO-1, heme oxygenase-1; NETs, neutrophil
extracellular traps; NTS, nontyphoidal Salmonella; PMN, polymorphonuclear cells; ROS,
reactive oxygen species; SCV, Salmonella containing vacuoles
enterica (often nontyphoidal Salmonella [NTS]) and Streptococcus pneu-
moniae as the most commonly isolated organisms.10 Laboratory
diagnosis for microbiological pathogens in Africa remains poor, with
insufficient infrastructure and related funding. Despite challenges in
detection, Ao et al. have estimated that NTS causes 3.4million cases of
bacteremia globally each year, of which the majority (1.9 million cases
and 380,000 deaths) are in children and young adults in sub-Saharan
Africa.11 In Kenya, 70% of these deaths occur within 2 days of admis-
sion to hospital,12 providing a very narrow window for effective inter-
vention. Further, multiple drug-resistant NTS serotypes have been
reported in East and Southern Africa, with sequence type 313 (ST313)
seen as a distinct lineage associated with septicemia.13,14 Increasingly,
lack of access to effective and affordable antibiotics may lead to even
higher morbidity andmortality in low-income settings.
NTS thrives in the intestinal environment where, in otherwise
healthy hosts, localized gastroenteritis allows NTS to outcompete the
microbiota, causing diarrhea and promoting transmission.15 However,
the infection can “escape” the gut and invade other tissues, eventually
becoming systemic, particularly when the host is immunocompro-
mised.Onewell-documented risk factor for invasiveNTS isPlasmodium
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falciparum malaria.16,17 Plasmodium, the causative agent of malaria,
is transmitted to humans through the bite of the female Anopheles
mosquito causing a range of clinical manifestations including anemia,
metabolic acidosis, and end-organ failure.18 In The Gambia, the
incidence of invasive NTS infection mirrors that of malaria, peaking
during the annual rainy season, and in one study, 43% of children with
Salmonella bacteremia had concurrent P. falciparum infections.19 In
Tanzania, invasive NTS in young children is highly associated with
recent malaria infection, with 78% of NTS cases having recently
received antimalarial medication and 82% of cases being anemic.20
Intriguingly, recent (past) malaria infection is a higher risk factor
for NTS bacteremia than is acute (current) infection.21 Therefore,
although children with severe acute malaria have been noted to be
at high risk of developing invasive NTS,22 a picture is emerging in
which even low-density or recently cleared malaria infections are a
significant contributor to invasive NTS. Finally, evidence that carriage
of sickle cell trait (that protects frommalarial anemia) reduces the risk
of contracting invasive NTS23 and that intensive efforts in the last 15
years to reduce the prevalence and incidence of malaria across Africa
have been accompanied by marked falls in the incidence of invasive
bacteremia, and especially invasive NTS24,25 serves to reinforce the
clinical observations linking these two diseases and suggests a related
underlying pathophysiology.
2 INTESTINAL AND INVASIVE NTS
INFECTIONS
Salmonella can infect a broad host range (e.g., pigs, cattle, chickens,
and humans) causing varying levels of damage, from enteric fever to
severe gastroenteritis to asymptomatic carriage, depending on the
particular serovar, typically defined by expression of LPS, flagellar, and
capsular Vi antigens.26 With over 2500 known serovars,27 ster-
ile immunity through natural infection or vaccination remains
elusive.28,29 The human-restricted typhoidal serovars (Salmonella
typhi and Salmonella paratyphi) are associated with systemic infection
and carriage in the gallbladder30 but, intriguingly, these are not the
serovars that are associated with malaria infections. Rather, malaria
is associated with invasive disease caused by nontyphoidal serovars
that can infect a broad range of different host species and are normally
restricted to the intestine.17 Invasion of NTS through the intestinal
mucosa can occur via their uptake by dendritic cells extruding den-
drites between enterocytes into the intestinal lumen (paracellular
uptake), via direct invasion of enterocytes or by passage through M
cells of the Peyers Patches31 (Fig. 1), and this is dependent on a degree
of inflammation.32,33 Bacterial invasion triggers the IL-23/IL-18
inflammatory axis leading to T cell activation and production of inflam-
matory cytokines (including IFN-𝛾 , IL-17, and IL-22) and chemokines
(CXCL1 and Mip2),34–36 eventually resulting in edema and infiltration
of monocytes and neutrophils into the lamina propria,37 which are
hallmarks of NTS pathology.
Although phagocytes, such as neutrophils and macrophages,
are efficient in their uptake of NTS, the bacteria can disable the
antibacterial machinery of macrophages to create Salmonella con-
taining vacuoles (SCVs) within which they can persist and replicate.38
Proteins encoded within Salmonella pathogenicity island-2 block lyso-
somal fusion allowing evasion of ROS-mediated killing.39 Ultimately,
clearance of bacteria from phagocytes is mediated by IFN-𝛾 , which
induces breakdown of the SCV,40 releasing bacteria into the cytosol.
Bacterial products now present in the cytosol can induce pyroptosis, a
formof cell death involving both canonical andnoncanonical inflamma-
some signaling with caspase-1 and NLRP3 or caspase-11 (in mice) and
caspase-4 and caspase-5 (in humans), which lead to activation of IL-1
and IL-18.41–43 Bacteria released from disintegrating macrophages
are cleared by neutrophils, a process that has been termed
“phagocyte roulette.”44
Neutrophils, also called polymorphonuclear cells (PMNs), are ter-
minally differentiated leukocytes with distinctive lobulated nuclei and
contain antimicrobial cytoplasmic granules. PMNs are the most abun-
dant white blood cell, with 1 × 1011 new cells emerging from the bone
marrow daily. They are typically thought to have a very short lifespan
in blood (∼7–24 hours45), although infection may delay apoptosis and
increase lifespan.46–48 During infection and inflammation, PMNs are
quicklymobilized to sites of injury. In the blood vessel, activated PMNs
adhere to endothelium, extravasate and migrate along chemokine
gradients to infectious foci.
PMNs are professional phagocytes, which use receptor-
mediated phagocytosis to internalize pathogens and debris into
phagolysosomes.49 Intracytoplasmic granules containing cathepsins,
elastases, and myeloperoxidases fuse with the phagolysosome to
digest internalized pathogens, in a process known as degranulation;
leakage of granules or their contents into the extracellular milieu
can be a significant cause of tissue damage during infection.49,50
Release of reactive oxygen species (ROS), produced via an NADPH
oxidase-dependent process, into the phagolysosome is an additional,
very important, bactericidal mechanism. PMNs can also kill extracel-
lular pathogens by degranulation, secretion of ROS, or the release
of neutrophil extracellular traps (NETs). NETs consist of external-
ized decondensed chromatin decorated with granular proteins and
histones to prevent the dissemination of pathogens.51,52 Serine
proteases and histones provide antimicrobial activity against trapped
pathogens. NETs also permit subsequent phagocytosis by proximate
phagocytes (Fig. 2).
Although macrophages can be permissive to NTS growth, inflam-
matory monocytes and neutrophils are efficient in killing Salmonella
through oxidative stress.53 In the intestine, both mucosa-associated
and luminal neutrophils engulf Salmonella.54 However, infiltrating
PMNs also promote intestinal inflammation,55 thereby increasing
the risk of bacterial invasion, and produce ROS, which can trans-
form carbon sources such as thiosulfate in the intestinal lumen
into tetrathionate and the microbial fermentation product 1,2-
propanediol, allowing NTS to outgrow the competing microbiota.32,33
PMNs also release calprotectin into the intestinal milieu where
it sequesters zinc, further restricting the growth of the intestinal
microbiota.56 Therefore, although PMNs can limit bacterial growth
and prevent overwhelming infection, NTS can exploit neutrophil-
mediated inflammation in the intestine to ensure its survival and
eventual transmission.53,57
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F IGURE 1 NTS intestinal immune response. NTS is a fecal-oral pathogen, which thrives in the inflamed intestine. Tissue invasion in the distal
intestine can be via direct invasion, uptake by M cells, or through paracellular spaces. Uptake by dendritic cells can initiate inflammation through
the IL-23/IL-17 axis. Th17 cells promote neutrophil influx via the induction of neutrophil chemokines. NTS is able to persist within the Salmonella-
containing vacuole ofmacrophages, whereas neutrophils are efficient atNTS clearance. Systemic dissemination to draining lymph nodes is through
CD18+ phagocytes. During experimental malaria, NTS colonization resistance is lowered, although it is unclear if there is an increase in tissue
invasion. Regardless, inflammation (with reduced PMN influx) is reduced due to increased IL-10 concentrations. However, the role of IL-10, and
potentially HO-1, on intestinal neutrophil function and role for increased systemic dissemination are unclear
3 PATHOPHYSIOLOGY OF NTS–MALARIA
COINFECTIONS
Clinically, NTS infections in patients in Africa are not associated
with overt diarrheal disease58 suggesting that underlying coinfec-
tion may ameliorate the intestinal inflammation typically associated
with NTS. Evidence from coinfection models supports this idea
(Table 1): intestinal inflammation is markedly reduced in both mice
and macaques coinfected with malaria and NTS compared to animals
infectedwith NTS alone and this is associatedwith reduced neutrophil
influx and lower levels of IFN-𝛾 and IL-1759 (Fig. 1). In mice, this
reduction in intestinal inflammation is mediated by IL-10,59 a potent
anti-inflammatory cytokine, which is essential for minimizing tissue
damage duringmalaria infections (discussed in detail below). Although
reducing intestinal inflammation might be expected to reduce the
likelihood of invasion of NTS into the lamina propria and subsequent
systemic dissemination, malaria infection has other, less beneficial
consequences for the gut. In humans, acute malaria infection, in the
apparent absence of gastrointestinal pathogens, is commonly associ-
ated with mild to moderate diarrhea, perhaps indicative of dysbiosis
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F IGURE 2 Neutrophil function. PMN extravasation is initiated by inflammatory mediators, which stimulate the upregulation of adhesion
molecules, such as selectins, on endothelial cells allowing tethering and rolling of PMN. Chemokine gradients cause PMNs to “crawl” toward the
site of infection until an endothelial junction is reached where diapedesis can occur. At the site of infection, neutrophils have numerous functions
including phagocytosis, degranulation, and NETosis. Phagocytosis involves the ingestion of a pathogen into a phagolysosome containing granule
proteins and ROS, to disable and digest internalized pathogens. Degranulation can also occur extracellularlywhere granular proteins, such asMPO
andelastase, andROScanbe released fromPMNs.Anovel functionofPMNs isNETosis,which is the releaseofNETs. Thesedecondensed chromatin
fibers decoratedwith histones and granular proteins trap and kill pathogens to prevent further dissemination. It is known that duringmalaria infec-
tion, neutrophils maintain the ability to phagocytose NTS; however, PMNs display impaired ROS production. Mechanisms still to be investigated
include: maturation, extravasation, migration, degranulation, and NETosis
and or increased intestinal permeability.60,61 In mice, malaria infection
causes a dysbiosis, changing the composition of the microbiota and
providing a foothold for colonization of the intestinal epithelium
by NTS and E. coli.62 Increased colonization, taken together with
increased gut permeability and reduced availability of neutrophils
to control the bacterial infection, may explain why, 48 h after chal-
lenge with NTS, bacterial loads in the draining mesenteric lymph
nodes are 100-fold higher in malaria-coinfected mice than in mice
without malaria.59
Whether increased NTS colonization or lymph node dissemina-
tion directly increases the risk of systemic spread is not yet clear
but major defects in control of systemic NTS are evident in malaria
coinfection: bacterial loads in blood, liver, spleen, and bone mar-
row after intraperitoneal injection of Salmonella Typhimurium (bypass-
ing any intestinal contribution) were 1000–10,000-fold higher in
Plasmodium yoelii-infectedmice than inmalaria-uninfectedmice.63,64
4 HEMOLYSIS, HEME OXYGENASE-1,
AND NEUTROPHIL FUNCTION DURING
MALARIA–NTS COINFECTION
Anemia is a heterogeneous condition defined as a reduction in circulat-
ing hemoglobin, the iron containing metalloprotein abundant in RBC,
which ferry oxygen through the blood. One important cause of ane-
mia is direct lysis of RBC (hemolysis) due to autoimmune conditions or
infection. Somepathogens secretehemolysins (e.g., Staphylococcus spp.,
Streptococcus spp., and Clostridium spp.) while other pathogens repli-
cate inside, and ultimately lyse, RBC (e.g., Babesia spp., and Bartonella
spp., and Plasmodium spp.). In malaria infection, direct destruction of
RBC by parasitization is compounded by eryptosis of large numbers of
uninfected RBC by processes that are still incompletely understood;65
however, complement-mediated opsonization of bystander RBC has
been noted.66,67 Regardless of themechanism, hemolysis results in the
release of hemoglobin, or its breakdownproduct heme, into the plasma
(Fig. 3). Free heme is prooxidant and highly cytotoxic, contributing to
endothelial injury and hypertension.68,69 Extracellular hemoglobin is
scavenged by haptoglobin, which then binds to CD163 on the sur-
face of macrophages and is internalized and degraded. Similarly, free
heme is sequestered by hemopexin and internalized by binding to
CD91. Intracellular heme is then degraded into equimolar amounts
of iron, carbon monoxide, and biliverdin through the action of heme
oxygenase (HO). Under homeostatic conditions, this process is medi-
ated by the constitutively expressed HO isoform, HO-2. However,
under conditions of hypoxia, oxidative stress, or infection (e.g., pres-
enceof LPS), the inducible isoformHO-1 (encodedbyhemeoxygenase-
1 gene [hmox1]) is upregulated to prevent heme-induced pathology
and ensure efficient iron recycling.70,71 Importantly, plasma heme and
HO-1 concentrations are raised during both acute72 and subclinical73
P. falciparum malaria infections in humans, and during acute P. yoelii
infection in mice,63 competitive inhibition of HO-1 enzyme activ-
ity restores the ability of P. yoelii-infected mice to control systemic
NTS infections.63 Moreover, hmox1 induction increases NTS growth in
murinemacrophages,74 indicating that hemolysis (via heme andHO-1)
rather thanmalaria, per se, may be the true risk factor for invasiveNTS
disease in malaria patients. In support of this notion, individuals with
sickle cell anemia, which gives rise to periodic hemolytic crises, are also
highly susceptible to invasive NTS disease75,76; similarly, induction of
acute hemolysis by antibody-mediated RBC lysis77 or phenylhydrazine
treatment63 also renders mice highly susceptible to NTS.
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TABLE 1 Animal models of malaria and salmonella coinfection
Reference Animal (strain) Plasmodium spp.
NTS strain
(serovar)
Route of NTS
challenge
NTS
challenge
after Plas-
modium Endpoint NTS-related outcome
Roux et al.77 Mus (CBA/J) P. yoelii nigeriensis IR715 (ATCC
14028)
Intragastric Day 0 Day 5 Increased CFU in Spleen,
liver, and Peyer’s patch.
Cunnington
et al.63
Mus (C57BL/6) P. yoelii 17XNL 12023-GFP Intraperitoneal Day 15 18 h Increased CFU in blood,
spleen, and liver.
Chau et al.124 Mus (CBA/J) P. yoelii 17XNL IR715 (ATCC
14028)
Intragastric Day 10 Day 14 L-Arginine & L-Citrulline
supplementation during
P.y. reduces NTS burden in
mesLN
Lokken et al.64 Mus (CBA/J) P. yoelii nigeriensis IR715 (ATCC
14028)
Intragastric Day 10 Day 12, 14 Increased CFU in liver (day
12/14), blood (day 14)
Mus (CBA/J) Intraperitoneal Day 10 Day 12, 13 Increased CFU in liver (day
12/13), blood (day 13)
Mus (C57BL/6J) Intragastric Day 10 Day 12 No increase in CFU, reduced
liver PMN chemokines
Mus (C57BL/6J) Intraperitoneal Day 10 Day 12 No increase in CFU
Mus (C57BL/6J
il10–/–)
Intragastric Day 10 Day 12 Reduces CFU in single &
co-infected, restored liver
PMN chemokines
Mus (C57BL/6J
il10Rflx:LysMcre)
Intraperitoneal Day 10 Day 12 IL-10R–/– myeloid cells; loss
in increased liver, blood
CFU
Mus (C57BL/6J
il10flx:LysMcre)
Intraperitoneal Day 10 Day 12 IL-10–/– myeloid cells; loss in
increased blood CFU
Mooney
et al.59
Macaca mulatta P. fragile IR715 (ATCC
14028)
Ligated ilieal
loops
Day 14, 15 8 h Reduced intestinal
inflammation to NTS
Mus (CBA/J) P. yoelii nigeriensis Intragastric Day 10 Day 12 Reduced intestinal
inflammation to NTS,
increasedmesLNCFU
Mus (C57BL/6J) Day 10 Day 12 Reduced intestinal
inflammation&PMN influx
Mus (C57BL/6J
il10–/–)
Day 10 Day 12 Restored intestinal
inflammation & PMN
influx in IL-10–/–
Mooney
et al.125
Mus (C57BL/6) P. yoelii 17XNL BRD509 Intravenous Day 14, 28 Day 17, 31 Increased CFU in liver
Mus (C57BL/6J-
Slc11a1+/+)
Intravenous Day 14 Day 17 No increase in CFU
Mus (CBA/J) Intragastric Day 14 Day 18 No increase in CFU
Mooney
et al.62
Mus (C57BL/6J) P. yoelii nigeriensis IR715 (ATCC
14028)
Intragastric Day 10 Day 11 Increased NTS colonization
in feces
Mus (C57BL/6J) -
Germ Free
Day 10 Day 11 Increased NTS colonization
in feces with fecal donation
from P. yoelii-infectedmice
into germ-freemice
Lokken et al.79 Mus (CBA/J) P. yoelii nigeriensis IR715 (ATCC
14028)
Intragastric Day 10 Day 12, 14 Increased CFU in liver (day
14 only)
Mus (C57BL/6J
il10–/–)
Intraperitoneal Day 10 Day 12 Reduced CFU in liver in
IL-10–/–
The first indication that hemolysis has a negative impact on neu-
trophil function, and thus that neutrophil dysfunction might underlie
increased risk of invasive bacterial disease in people with malaria or
other hemolytic diseases, came frommouse coinfection studies where
circulating neutrophils from malaria-infected and phenylhydrazine-
treated mice were shown to efficiently phagocytose S. Typhimurium
butwereunable to kill; viable bacteria persisted and, indeed, replicated
inside neutrophils, whichwere severely deficient in ROS production.63
Of note, in vitro, heme pretreatment reduced phagocytosis of E. coli
by human and murine neutrophils78 and high circulating heme during
P. falciparum infection can reduce in vitro phagocytosis of Salmonella
by neutrophils.72 The observation that treatment with a synthetic
heme polymer, hemin, induced similar neutrophil defects and that
these defects can be reversed by competitive inhibition of HO-1,
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F IGURE 3 Anemia, HO-1, and IL-10. Dur-
ing malaria infection, anemia can occur through
direct lysis of parasitized RBCs (hemolysis)
or through eryptosis of uninfected RBCs—
which are taken up by phagocytes through
the phosphatidylserine receptor (PSR). Hemol-
ysis results in release of hemoglobin (Hb),
which can be further degraded to free heme.
Serum scavenger proteins haptoglobin (Hpt)
and hemopexin (Hpx) bind Hb and heme before
uptake by phagocytes through CD163 and
CD91, respectively. Intracellular heme is then
degraded to iron, biliverdin, and carbon monox-
ide via the enzyme HO-2 or the inducible iso-
form, HO-1. HO-1 can also be induced by IL-
10 receptor signaling. The impact of IL-10 and
HO-1 during malarial anemia and hemolysis on
phagocyte function remains poorly defined
then provided a link among malaria, hemolysis, HO-1, and neutrophil
dysfunction.63 ROS-defective neutrophils have also been observed in
children with acute malaria; importantly, these defects persist for up
to 8 weeks after treatment,72 perhaps explaining why children with
recent (past) malaria infection remain susceptible to invasive NTS.21
Plasmodium infection also reduces neutrophil mobilization into
infected tissues including blood63 and, as discussed above, intestine59
and liver64; infiltration of inflammatorymonocytes into the liver is also
impaired.79 Although this may be due in part to the anti-inflammatory
effects of IL-10 (asdescribedbelow), there arealso cell-intrinsic effects
within developing neutrophils. Neutrophil precursors in the bonemar-
row (i.e., granulocytemacrophage progenitor cells) of malaria-infected
mice express HO-1 and have unusual surface phenotypes (F4/80
and Gr-1 expression).63 It has been shown that HO-1 reduces neu-
trophil influx into the inflamed lung71 suggesting a causal relationship
betweenHO-1 and reduced neutrophil migration butmuchmorework
is needed to fully characterize neutrophil maturation and function dur-
ing malaria infection and to determine the extent to which the altered
phenotype is mediated by the heme/HO-1 pathway.
5 THE ROLE OF IL-10 IN MALARIA
NTS COINFECTION
IL-10 is a potent anti-inflammatory cytokine and an important regu-
lator of inflammation-induced pathology,80 it is therefore no surprise
that systemic IL-10 concentrations are elevated in highly inflammatory
diseases such as sepsis81,82 and malaria.83,84 More surprisingly, how-
ever, circulating IL-10 is also elevated during mild/uncomplicated83,85
and asymptomatic/subclinical malaria infections73,86; indeed these
cases may represent successful balancing of inflammation-mediated
parasite control and effective regulation of inflammation by IL-10. In
malaria, IL-10 can come from both innate and adaptive immune cells,
including Th1-derived regulatory T cells that coproduce IFN-𝛾 and IL-
10,87–89 and plays an essential role in both adaptive humoral immunity
(promoting differentiation of T-bet+ germinal center B cells)90,91 and
limiting tissue damage.92–94
The anti-inflammatory properties of IL-10 include rendering
phagocytes refractory to activation and/or directing macrophage
polarization to a regulatory “M2" phenotype.95,96 The impact of IL-10
on neutrophil function is well described, reducing recruitment and
migration in response to anaphylatoxins and ultimately bacterial
clearance.97,98 Further, neutrophils themselves can be a source of
IL-10, induced by regulatory T cells.99 During malaria NTS coinfection
in mice, LysM-expressing cells are a significant source of IL-10 and
its ablation reduces NTS bacteremia.64 IL-10 suppresses neutrophil
function through the activation of STAT3 and suppressor of cytokine
signaling 3,100,101 leading to the down-regulation of IFN regulatory
factor and NF-𝜅B family transcription factor.102 In addition, HO-1 can
be directly induced by IL-10103 (Fig. 3). One hypothesis, therefore, is
that malaria-induced neutrophil dysfunction results from hemolysis-
and IL-10-driven HO-1 induction. In support of this hypothesis, in
a recent study of persistent malaria infections, we have found that
heme drives inflammation, that parasite density and inflammation
then drives IL-10 production, and that heme and IL-10 both then
induce HO-1.73
6 COMPLEMENT DEPLETION
DURING MALARIA
Complement proteins play an essential role in orchestrating inflamma-
tion and pathogen clearance,104,105 including during Salmonella
infection.106,107 In brief, the classical pathway is activated by
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F IGURE 4 Complement depletion. During malaria infection, sys-
temic complement activation occurs due to deposition on both
infected and uninfected RBCs. This results in reduced concentrations
of circulating C3 and C5 and generation of anaphylatoxins (C3a and
C5a). The consequences that may impact PMN function are 2-fold;
(1) a reduction inC3 available for deposition on extracellularNTS lead-
ing to opsonization and migration and/or (2) excessive C5a reducing
CD88 (C5aR) on neutrophils leading to reducedROS and cytokine pro-
duction. Additional work is needed to clarify the impact of comple-
ment activation and subsequent depletion during malaria on risk to
NTS bacteremia
antibody (IgM and IgG) and the alternative pathway is activated by
spontaneous hydrolysis of C3.108 C3 becomes membrane bound
and cleaves C5, creating soluble C5a and membrane-bound C5b.109
The complement anaphylatoxin C5a is a potent chemoattractant for
neutrophils while also inducing expression of cell adhesion molecules
on endothelial cells (such as P-selectin) that permit neutrophil translo-
cation into tissue.110 C5a also enhances neutrophil resistance to
apoptosis,111 allowing the cells more time to perform effector func-
tions. After bacterial uptake, maturation of the neutrophil phagosome
requires its fusion with antimicrobial granules and the production of
reactive superoxide anions (O2
–) following G oxidase assembly on
the phagolysosomal membrane.112 Assembly of NADPH oxidase is
primed through the interaction of C5a and its receptor (C5aR and
CD88).113,114 Indeed, the E. coli-induced oxidative burst in phagocytes
is almost entirely dependent on CD88 signaling.115 Opsonization and
killing of invasive NTS strains by neutrophils isolated from Malawian
children require both antibodies and complement.107
Complement activation on the surface of uninfected RBCs presum-
ably increases the rate of turnover ofRBCsduringmalaria infection,116
possibly due to reduced availability of complement regulatory proteins
such as CD55.117–119 Complement-mediated red cell lysis not only
exacerbates the anemia associated with malaria, but will also increase
circulating heme and therefore HO-1 concentrations and reduce the
availability of complement components,120 whichmay impair ability to
control invasive bacterial infection (Fig. 4). Hypothetically, excess C5a
in plasma may reduce CD88 on PMNs, and thus reduce the oxidative
burst. Further, depletion of complement proteins (with concomitant
reduction in expression of endothelial selectin) and reduced genera-
tion of anaphylatoxins could reduce neutrophil migration into infected
tissues. Further studies are required to determine the significance of
complement activation and complement consumption during malaria
and risk of invasive NTS.
7 CONCLUDING REMARKS
Wehave provided a rational for considering that hemolysis and inflam-
mation, leading to induction of HO-1 and IL-10 and activation of com-
plement, duringmalaria infectionsmight all contribute to the increased
susceptibility to bacterial coinfection. It is likely that these path-
ways synergize to increase risk of invasive NTS: in malaria-infected
mice, both exogenous IL-10 and anemia were required for increased
bacteremia64; HO-1 is induced both by heme and by IL-10; and the car-
bonmonoxide generated from heme catabolism can induce bothHO-1
and IL-10.121,122 Ultimately, it is important to define how these fac-
tors may converge to alter neutrophil biology. Through this, we may
begin to understand if targeted treatment, or even prophylactic anti-
malarial treatment, can improve neutrophil function and so reduce
the burden of invasive bacterial disease in malaria endemic popula-
tions. Given the importance of neutrophils in clearance of NTS, work
is now needed to better describe the impact of malaria on this innate
immune cell.
The risk of invasiveNTS duringmalaria in sub-Saharan Africa is well
defined for acute malaria infection. However, the majority of malaria
infections in the world are asymptomatic, with chronic, low-density
infections.123 As recent and low-density malaria infections are a risk
factor for NTS bacteremia,21 it is also important to understand if
hemolysis, and resulting induction of HO-1 and IL-10, seen during
these “asymptomatic” infections73 reaches the threshold needed for
neutrophil dysfunction. In other words, in addition to defining the
pathways leading to neutrophil dysfunction, we also need to identify
the point at which the balance tips from these being host protective
to increasing the risk to invasive NTS. Importantly, these pathways
may contribute to severe bacterial disease even in the absence of
malaria infections: in sepsis patients, we have observed that raised
concentrations of heme,HO-1, and IL-10 are positively correlatedwith
8 MOONEY ET AL.
disease severity and mortality.82 Also, while “invasive” NTS is seen in
immunocompromised hosts (such as those with malaria infection), it
remains unclear if this is due to increased intestinal invasion, increased
dissemination from draining lymph nodes, failure to control systemic
bacterial replication, or a combination of any of these. Moreover,
the extent to which this is primarily a neutrophil defect requires
further exploration.
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